{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:12Z","timestamp":1783075932708,"version":"3.54.6"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/fpc.0b013e328311a917","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T03:15:25Z","timestamp":1228792525000},"page":"91-94","source":"Crossref","is-referenced-by-count":49,"title":["Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia"],"prefix":"10.1097","volume":"19","author":[{"given":"Rainald","family":"M\u00f6ssner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schuhmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Cvetanovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris B.","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"W\u00f6lwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Gaebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041444-199906000-00010","article-title":"A common C-1018G polymorphism in the human 5-HT1A receptor gene","volume":"9","author":"Wu","year":"1999","journal-title":"Psychiatr Genet"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-006-0543-8","article-title":"Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635","volume":"189","author":"Frankle","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2003.11.016","article-title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia","volume":"55","author":"Yasuno","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4088\/JCP.v68n1116","article-title":"Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia","volume":"68","author":"Gaebel","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00406-004-0509-y","article-title":"Pharmacological long-term treatment strategies in first episode schizophrenia \u2013 study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia","volume":"254","author":"Gaebel","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00406-003-0468-8","article-title":"German research network on schizophrenia \u2013 bridging the gap between research and care","volume":"253","author":"W\u00f6lwer","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R8-10-20210212","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1176\/ajp.2006.163.10.1826","article-title":"Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients","volume":"163","author":"Reynolds","year":"2006","journal-title":"Am J Psychiatry"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200901000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T21:49:21Z","timestamp":1618350561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200901000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e328311a917","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1144895.601988","asserted-by":"object"}]},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}